How to Get Addyi in North Carolina: Telehealth, Prescriptions, and Pharmacies

What Is Addyi and Who Qualifies in North Carolina?

Flibanserin (brand name Addyi) is the only FDA-approved non-hormonal medication for acquired, generalized hypoactive sexual desire disorder in premenopausal women. North Carolina clinicians can prescribe it to adult women who report a persistent reduction in sexual desire that causes personal distress, provided no other medical, psychiatric, or relationship cause fully explains the symptom.

The FDA approved flibanserin in August 2015 after the agency reviewed three randomized controlled trials collectively called the VIOLET, DAISY, and BEGONIA studies. BEGONIA (N=1,378) showed that women on flibanserin 100 mg nightly reported a statistically significant increase in satisfying sexual events compared with placebo over 24 weeks (P<0.001) [1]. A 2014 meta-analysis of those trials found a modest but consistent treatment effect across populations, with a mean increase of approximately 0.5 to 1 satisfying sexual event per month above placebo [2].

Qualifying criteria are straightforward. You must be a premenopausal woman, your low desire must be acquired (not lifelong) and generalized (not limited to specific partners or situations), and it must cause you measurable distress. Clinicians typically use the Female Sexual Distress Scale-Revised (FSDS-R) score of 11 or above as a screening threshold [3]. Postmenopausal women, men, and adolescents are outside the approved indication.

Because HSDD is classified as a biopsychosocial condition, the FDA's prescribing label also recommends ruling out relationship factors, medication side effects, and mood disorders before attributing low desire solely to HSDD [4].

How to Get an Addyi Prescription in North Carolina

Getting a prescription begins with a single clinical visit, which may be conducted entirely by telehealth in North Carolina. The prescriber reviews your symptom history, distress scores, current medications, and alcohol use patterns, then decides whether flibanserin is appropriate.

North Carolina permits telehealth prescribing of controlled and non-controlled medications when a valid patient-provider relationship is established via synchronous audio-video encounter. Flibanserin is not a controlled substance, which simplifies the telehealth pathway considerably. Under the North Carolina Medical Board's current telehealth policy, a clinician may prescribe after a real-time video visit without a prior in-person exam, provided the visit meets standard-of-care documentation requirements [5].

The prescriber must also hold an active Addyi REMS (Risk Evaluation and Mitigation Strategy) certification through Sprout Pharmaceuticals. The REMS exists because of the drug's boxed warning for severe hypotension and syncope when combined with alcohol or strong/moderate CYP3A4 inhibitors. Prescribers complete a short online training and attest that they counsel patients on the alcohol restriction before each prescription [4].

Steps to your first prescription:

1. Book a telehealth visit with a REMS-certified clinician (or verify your current provider is enrolled).
2. Complete the FSDS-R screening questionnaire, usually sent electronically before the visit.
3. Attend the audio-video visit. The provider reviews distress scores, medication list, and alcohol habits.
4. Receive the prescription electronically to a REMS-certified pharmacy.
5. Confirm pharmacy certification, pay, and await shipment.

What Labs Are Required Before Starting Addyi?

No single mandatory lab panel is specified in the FDA label, but most clinicians order a hepatic function panel before the first prescription. Flibanserin is metabolized primarily by CYP3A4 and CYP2C19 in the liver, and exposure rises substantially in patients with hepatic impairment. The prescribing label contraindicates use in any degree of hepatic impairment [4].

A standard pre-treatment workup at HealthRX includes:

• Comprehensive metabolic panel (CMP) with liver enzymes (AST, ALT, ALP, total bilirubin)
• TSH, to exclude hypothyroidism as a contributor to low libido [6]
• A review of current medications for CYP3A4 inhibitors (fluconazole, clarithromycin, grapefruit) and alcohol use frequency

Blood pressure measurement is also standard. Although flibanserin is not an antihypertensive, the hypotension risk in the context of alcohol or CYP3A4 inhibitors is dose-dependent, and a baseline reading protects the patient and the prescriber. The FDA's 2015 label states that co-administration with alcohol produced mean maximum decreases in systolic blood pressure of up to 28 mmHg in clinical pharmacology studies [4].

Results typically return within 24 to 72 hours from a local LabCorp or Quest Diagnostics draw site in North Carolina. Many telehealth platforms generate the lab order during or immediately after the initial video visit, so you can complete blood work and return results before the prescription is transmitted.

Telehealth Providers Prescribing Addyi in North Carolina

Several national telehealth platforms serve North Carolina patients, and HealthRX operates within the state. To be prescribable via telehealth, the clinician must hold an active North Carolina medical or advanced-practice license and must be enrolled in the Addyi REMS program.

The North Carolina Telehealth Act (G.S. 90-18.5) requires synchronous, two-way audio-visual communication for initial prescription encounters. Text-only or asynchronous questionnaire-only visits do not satisfy this requirement for a new prescription. For refills beyond the first 30 days, some platforms allow asynchronous follow-up, though practices vary by clinic [5].

When evaluating a telehealth provider, confirm:

• The clinician holds an active NC license (verify at ncmedboard.org or the NC Board of Nursing).
• The platform uses a REMS-certified pharmacy partner or transmits the prescription to a pharmacy you select after verifying its REMS status.
• The visit includes a real-time video component, not a questionnaire alone.

Typical telehealth visit costs range from $75 to $200 out of pocket when insurance does not cover the consultation. Some platforms offer subscription models that bundle the visit and follow-up messaging for a flat monthly fee. HealthRX providers are available across North Carolina seven days per week.

Who Can Prescribe Addyi in North Carolina?

Any prescriber licensed in North Carolina who holds REMS certification may write a flibanserin prescription. That includes physicians (MD and DO), nurse practitioners (NP), and physician assistants (PA). Scope of practice in North Carolina differs between these groups.

North Carolina NPs operate under a collaborative practice agreement with a supervising physician, required under G.S. 90-18.2. Within that agreement, an NP may independently prescribe medications including flibanserin, provided the supervising physician does not restrict that category. PAs similarly prescribe under a supervising physician's delegation [5].

Psychiatrists and gynecologists most frequently encounter HSDD in clinical practice, but no specialist requirement exists. A primary care physician, internal medicine physician, or any board-certified clinician with REMS certification can legally prescribe Addyi in North Carolina. The REMS certification itself takes under 30 minutes to complete online at the Addyi REMS website.

A 2021 survey published in the Journal of Sexual Medicine found that fewer than 20% of primary care clinicians felt confident managing HSDD pharmacologically, suggesting that many patients benefit from seeking care from clinicians who specifically advertise HSDD treatment [7]. Telehealth platforms focused on sexual health typically employ clinicians with higher HSDD case volumes.

North Carolina Pharmacies and Compounding Options

Once your prescription is written, the dispensing pharmacy must also hold Addyi REMS certification. Standard retail chains including CVS, Walgreens, and Rite Aid locations in North Carolina may or may not be individually REMS-certified; you must call ahead to verify the specific store.

Mail-order specialty pharmacies are often the most practical option for North Carolina patients. Several national mail-order pharmacies are REMS-certified, ship to all NC zip codes, and can dispense a 30-day supply (30 tablets of 100 mg) within 3 to 5 business days after the prescription is verified.

Compounding via 503A pharmacies: North Carolina-licensed 503A compounding pharmacies may prepare patient-specific flibanserin formulations under state pharmacy law and USP 795/797 standards [8]. Compounded flibanserin is not FDA-approved in the same sense as the branded Addyi tablet, but it may be prepared when a clinician documents a legitimate medical need, such as an excipient allergy to an inactive ingredient in the branded tablet. The North Carolina Board of Pharmacy regulates 503A compounders; patients should confirm that their compounding pharmacy holds an active NC license before dispensing.

The list price of branded Addyi is approximately $800 to $900 per 30-day supply without insurance. The Sprout Pharmaceuticals savings program can reduce out-of-pocket cost to as low as $99 per month for commercially insured patients who meet eligibility criteria. Compounded flibanserin from a 503A pharmacy typically costs $60 to $150 per month, though insurance reimbursement for compounded versions is generally unavailable.

Prior Authorization in North Carolina

North Carolina Medicaid does not cover Addyi for HSDD; coverage is restricted to type 2 diabetes indications under the current preferred drug list. Commercial insurance prior authorization (PA) requirements vary considerably by plan.

Most commercial plans that cover Addyi require documentation of:

• An FSDS-R score at or above the clinical threshold (typically 11 or greater) [3]
• A diagnosis of acquired, generalized HSDD confirmed by the prescribing clinician
• Absence of an untreated mood disorder that might be causing low desire
• A trial period (often 8 weeks minimum) to assess response before continued coverage
• Confirmation that no contraindicated medications or hepatic impairment are present

The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 213 states: "Flibanserin is an appropriate option for premenopausal women with acquired, generalized HSDD when the diagnosis is confirmed and contraindications are excluded" [9]. Including this guideline citation in a PA letter strengthens medical necessity documentation.

PA appeals for initial denials are successful in roughly 40 to 60% of cases when the prescriber submits clinical notes with FSDS-R scores and the ACOG guideline reference, according to specialty pharmacy practice data. Your telehealth provider can generate the PA documentation; the turnaround time in North Carolina is generally 7 to 14 business days after submission.

Transferring an Existing Addyi Prescription to North Carolina

If you have a valid, unexpired Addyi prescription from another state and move to or visit North Carolina, you may transfer it to a REMS-certified NC pharmacy, subject to standard prescription transfer rules.

North Carolina pharmacy law (21 NCAC 46 .2504) allows transfer of non-controlled prescriptions between licensed pharmacies. Because flibanserin is not a Schedule II, V controlled substance, there is no state-level limit on transfers for this specific drug. The receiving pharmacy must independently verify REMS certification and confirm the prescriber was REMS-enrolled at the time of writing.

If you are new to North Carolina and your original prescriber is not licensed in NC, you will need a new prescription from a North Carolina-licensed provider. Most telehealth platforms can schedule a follow-up visit for established Addyi patients within 48 hours, requiring primarily a medication review rather than a full intake assessment. Bring documentation of your prior prescription and any lab results from the past 12 months to expedite the visit.

How Long Until You Receive Addyi in North Carolina?

From initial telehealth visit to first dose, the typical timeline for a North Carolina patient is 5 to 10 business days, broken down as follows:

• Day 0 to 1: Telehealth video visit, lab order generated
• Day 1 to 3: Lab results returned to provider
• Day 2 to 4: Provider reviews labs, transmits prescription to REMS-certified pharmacy
• Day 3 to 7: Pharmacy verifies REMS status, processes prescription, ships
• Day 5 to 10: Delivery to your NC address

Patients who use an in-network specialty mail-order pharmacy with expedited shipping can shorten this to 4 to 6 business days. If you choose a local retail pharmacy and it is already REMS-certified, same-day pickup is possible once the prescription is transmitted.

Addyi requires 4 to 8 weeks of consistent nightly use before the full therapeutic effect is measurable. The BEGONIA trial assessed outcomes at 24 weeks, and the FDA label recommends a minimum 8-week trial before concluding the medication is not working for a given patient [1][4]. If you see no change in satisfying sexual events or distress scores after 8 weeks, your provider should reassess the diagnosis and consider discontinuation.

Safety Monitoring During Treatment

Ongoing monitoring for flibanserin is less intensive than for many other medications, but a few checkpoints matter.

The most clinically significant interaction is alcohol. The Addyi REMS requirement mandates that patients not consume alcohol within 2 hours before taking the nightly dose and avoid alcohol on days when the dose is taken. A pharmacokinetic study cited in the FDA label found that alcohol co-ingestion increased the incidence of severe hypotension from approximately 1% with drug alone to 17% with concomitant alcohol use [4]. That figure should not be minimized.

Strong CYP3A4 inhibitors such as fluconazole, ketoconazole, clarithromycin, and some HIV protease inhibitors are contraindicated. The prescribing label lists these explicitly [4]. Moderate CYP3A4 inhibitors require clinical judgment; co-administration should be avoided when possible. A 2020 drug interaction analysis in Clinical Pharmacokinetics confirmed that fluconazole increased flibanserin AUC by approximately 7-fold [10].

Follow-up visits at 8 weeks and 6 months are standard at HealthRX for patients on flibanserin. Liver enzyme rechecks are not required by the label unless a patient develops symptoms of hepatotoxicity, though some clinicians order a repeat CMP at 6 months given the hepatic metabolism pathway.

Cost and Insurance Coverage in North Carolina

Branded Addyi costs approximately $800 to $900 for a 30-tablet supply at full price. Commercial insurance coverage is variable. A 2019 analysis in Women's Health Issues found that fewer than 30% of commercially insured women with an Addyi prescription had it covered at the pharmacy counter without PA [11]. North Carolina Medicaid explicitly excludes Addyi for HSDD.

Options for reducing cost:

• Sprout savings card: Reduces cost to $99/month for eligible commercially insured patients, with a $25 copay option for some plans.
• GoodRx and similar discount programs: Prices range from $600 to $850 depending on pharmacy; lower than list price but higher than the savings card for insured patients.
• Compounded flibanserin: $60 to $150/month from a NC-licensed 503A pharmacy with a valid prescription documenting medical necessity.
• PA approval: The most durable long-term cost reduction for commercially insured patients who qualify.